Document is current

Article History

Received: 8 August 2024

Accepted: 22 October 2024

First Online: 1 November 2024

Declarations

:

: A.K.L., C.L., R.V., H.R.K., S.L., A.M.W., M.W. and M.A.W. do not report competing interests. M.L. has received speaker honoraria for presentations from STADA Pharma. G.K. has received research grants from the French Society of Neuroradiology and the French Society of Radiology. A.S. has received funding from the Deutsche Forschungsgemeinschaft (German Research Association) and the Helmholtz-Association outside the present study. He has received honoraria for presentations/advisory boards/consultations from Esteve, Desitin, Lobsor Pharmaceuticals, STADA, Bial, RG Gesellschaft, Zambon, NovoNordisk and AbbVie outside the present study. He has received royalties from Kohlhammer Verlag and Elsevier Press. He serves as an editorial board member of Stem Cells International. D.D. has received funding from the French Ministry of Health: PHRC grants, French Ministry of Research: ANR, European Preclinical Research: Coen, European Clinical Research: Horizon 2020, the charities: France Parkinson, ARSLA Foundation, Cure Parkinson Trust, the Foundations: University of Lille, Credit Agricole, Bettencourt, de France. He had consultancies: Scientific Advisory Board for Abbvie, Alterity, Orkyn, Air Liquide, Apopharma, Chiesi, Lundbeck, Everpharma and Boston Scientific, PTC Therapeutics, Inflectis, Cajal Neurosciences, AB sciences, Alzprotect, Orion and has equities: InBrain Pharma, InVenis Biotherapies. U.W. has received funding from the German Federal Ministry of Education and Research (BMBF) outside the present study. He has received speaker honoraria and travel grants from Bristol-Myers Squibb, Boehringer Ingelheim Pharma, Daiichi-Sankyo, Ipsen Pharma, Merz Pharmaceuticals, Pfizer Pharma, and an unrestricted research grant from Merz Pharmaceuticals outside the present study. He serves as Joint Editor-in-Chief of the European Journal of Ultrasound (Thieme, Stuttgart, Germany).